Needham Reiterates Hold on Definitive Healthcare
Portfolio Pulse from Benzinga Newsdesk
Needham analyst Ryan MacDonald has reiterated a Hold rating on Definitive Healthcare (NASDAQ:DH).

August 06, 2024 | 9:30 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Needham analyst Ryan MacDonald has reiterated a Hold rating on Definitive Healthcare (NASDAQ:DH).
The reiteration of a Hold rating suggests that the analyst does not see significant upside or downside in the short term. This neutral stance is likely to result in minimal immediate impact on the stock price.
CONFIDENCE 90
IMPORTANCE 50
RELEVANCE 100